This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep;58(3):465-6.

doi: 10.1016/j.eururo.2010.06.019.

Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole GL, Bostwick DG, Brawley OW, et al

Prasanna Sooriakumaran¹, Ashutosh Tewari

Affiliations

PMID: 20845542
DOI: 10.1016/j.eururo.2010.06.019

Comment

Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole GL, Bostwick DG, Brawley OW, et al

Prasanna Sooriakumaran et al. Eur Urol. 2010 Sep.

. 2010 Sep;58(3):465-6.

doi: 10.1016/j.eururo.2010.06.019.

Authors

Prasanna Sooriakumaran¹, Ashutosh Tewari

Affiliation

¹ LeFrak Center of Robotic Surgery, Weill Medical College of Cornell University, 525 East 68th St., New York, NY 10065, USA. prs2011@med.cornell.edu

PMID: 20845542
DOI: 10.1016/j.eururo.2010.06.019

No abstract available

PubMed Disclaimer

Comment on

Effect of dutasteride on the risk of prostate cancer.
Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group. Andriole GL, et al. N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127. N Engl J Med. 2010. PMID: 20357281 Clinical Trial.

Similar articles

Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole GL, Bostwick DG, Brawley OW, et al. REDUCE Study Group. N Engl J Med 2010;362:1192-202.
Madersbacher S. Madersbacher S. Eur Urol. 2010 Aug;58(2):312. doi: 10.1016/j.eururo.2010.05.016. Eur Urol. 2010. PMID: 20845533
Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole G, Bostwick D, Brawley O, et al. N Engl J Med 2010;362:1192-202.
Klotz L. Klotz L. Eur Urol. 2010 Aug;58(2):313. doi: 10.1016/j.eururo.2010.05.017. Eur Urol. 2010. PMID: 20845544
Words of wisdom. Re: effect of dutasteride on the risk of prostate cancer.
Bosland MC, Cremers RG, Kiemeney LA. Bosland MC, et al. Eur Urol. 2010 Oct;58(4):631-2. doi: 10.1016/j.eururo.2010.07.015. Eur Urol. 2010. PMID: 20848747 No abstract available.
Words of wisdom: Re: Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Tombal B, Lecouvet F. Tombal B, et al. Eur Urol. 2012 Jun;61(6):1265-6. doi: 10.1016/j.eururo.2012.03.028. Eur Urol. 2012. PMID: 22542091 No abstract available.
Dutasteride for the treatment of prostate-related conditions.
Slater S, Dumas C, Bubley G. Slater S, et al. Expert Opin Drug Saf. 2012 Mar;11(2):325-30. doi: 10.1517/14740338.2012.658040. Epub 2012 Feb 8. Expert Opin Drug Saf. 2012. PMID: 22316171 Review.

See all similar articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science